Extracted from this filing and checked against the source text.
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.9
Phio Pharmaceuticals Corp. issued up to 424,739 shares of Common Stock of warrant to H.C. Wainwright & Co., LLC for services as placement agent.
- Security
- warrant
- Shares
- up to 424,739 shares of Common Stock
- Purchaser
- H.C. Wainwright & Co., LLC
- Consideration
- services as placement agent
Exact text from the filing
Additionally, in connection with the above-mentioned offering, the Company agreed to issue to Wainwright or its designees as compensation, warrants to purchase up to an aggregate of 424,739 shares of Common Stock, equal to 7.5% of the aggregate number of Existing Warrants exercised in the offering (the “Placement Agent Warrants”) and, if the New Warrants are exercised for cash in the future, further warrants to purchase shares of Common Stock equal to the 7.5% of the aggregate number of New Warrants so exercised.
View on SEC.gov
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.95
Phio Pharmaceuticals Corp. issued up to 11,326,364 shares of Common Stock of warrant to holders of existing common stock warrants for exercise of existing warrants for cash and payment of $0.125 per New Warrant, aggregate $1,415,795.50.
- Security
- warrant
- Shares
- up to 11,326,364 shares of Common Stock
- Purchaser
- holders of existing common stock warrants
- Consideration
- exercise of existing warrants for cash and payment of $0.125 per New Warrant, aggregate $1,415,795.50
Exact text from the filing
In consideration for the exercise of such warrants for cash and the payment of an additional $0.125 per New Warrant (as defined below), or an aggregate of $1,415,795.50 for all New Warrants, the Company agreed to issue to the Holders new unregistered Series A Warrants (the “New Warrants”) to purchase an aggregate of up to 11,326,364 shares of Common Stock (the “New Warrant Shares”).
View on SEC.gov